Coverage
-
April 04, 2013
Ferring Pharmaceuticals Inc. on Thursday lost its bid to stop a Watson Pharmaceuticals Inc. fertility drug advertising campaign it alleges contains shoddy opinion polls and inaccurate effectiveness claims when a New Jersey federal judge ruled Ferring hasn't adequately proved it's been harmed.
1 other articles on this case.
View all »